Global Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Women With Moderate to Severe Endometriosis-associated Pain

NCT02143713 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

496

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometriosis

Interventions

DRUG: Elagolix

Sponsor

AbbVie